FirstCry's consolidated loss narrows 75% YoY to ₹12.6 Cr as margins near breakeven
PAT +75.1% YoY · revenue +14.1% · margins expanding
₹2,395.83 Cr
+14.1% YoY
₹-12.59 Cr
+75.1% YoY
-0.52%
+1.8pp YoY
₹-0.14
Brainbees Solutions (FirstCry), on a consolidated basis — the primary measure given the standalone/consolidated divergence below — reported Q2 FY27 revenue of ₹2,395.8 Cr, up 14.1% YoY and 13.7% QoQ, with a net loss of ₹12.6 Cr, down 75.1% YoY from ₹50.5 Cr and 71.4% QoQ from ₹44.0 Cr. Consolidated net profit margin improved to -0.5% from -2.4% a year ago and -2.0% last quarter, taking the group to the edge of breakeven. There is no material one-off distortion this quarter: exceptional items (retirement-benefit remeasurement and subsidiary inventory write-offs) were a modest ₹2.19 Cr loss versus ₹3.43 Cr a year ago, so the adjusted YoY PAT improvement (~77.9%) tracks close to the reported 75.1% — this is a genuine operating recovery, not an accounting artefact.
Q2 FY-2027 vs prior quarters
The India multi-channel segment — manufacturing, retail and digital baby/kids products domestically — grew revenue 18.6% YoY to ₹1,637.9 Cr, landing right at management's guided 'superior growth... 18% YoY' from the Q1 FY27 call, and its segment result swung to a ₹42.5 Cr profit from a loss a year ago. EBITDA-equivalent margin (profit before finance cost, depreciation and tax, over revenue) expanded to 5.6% from 4.8% YoY and 5.0% QoQ, consistent with management's prior guidance that margin recovery from the Q4 FY26 280-bps hit would be 'much faster' in Q2–Q3 and that crude/rupee cost pressure would be fully absorbed by end-Q2 — that appears to be playing out on this print.
The stock went into the print at ₹160.4, down 11.7% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.
FY27: 'Superior growth' vs FY26 on track (India multi-channel 18% YoY). Margin recovery from 280 bps Q4 loss expected 'much faster' in Q2–Q3; crude/rupee impact fully recovered by end Q2. Store expansion 90–100 net adds in FY27. International path to breakeven 'sooner than you think' but no specific quarter given.
— This quarter: met
Not every piece of the guidance has landed yet: the International segment (UAE/Saudi) grew revenue 5.8% YoY to ₹249.3 Cr but its segment loss widened sequentially to ₹22.0 Cr from ₹18.9 Cr in Q1 FY27, even as it narrowed from ₹24.4 Cr a year ago — management's 'breakeven sooner than you think' call (no specific quarter given) has not materialised this quarter. The Globalbees D2C segment fared better, with its loss narrowing to ₹1.9 Cr from ₹10.7 Cr YoY on ₹530.6 Cr revenue (+7.7% YoY). No specific Street consensus estimate for this quarter's revenue or PAT turned up despite multiple searches, so vs-Street is left unknown rather than inferred; qualitative brokerage commentary ahead of the print had flagged Q2 FY27 margin recovery as the key swing factor for the stock, which is directionally consistent with the print. The quarter also saw subsidiary-level corporate activity — a 10.09% stake pickup in Dynamic IT, an increased stake in JW Brands, GlobalBees' stake sale in Mush Textile (~₹5.69 Cr) and an NCLT rejection of an insolvency plea against GlobalBees Brands — none of which show up as line-item swings in this result but are relevant to the subsidiary count and portfolio churn evident in the segment numbers.
W1
Whether consolidated PAT crosses into profit in Q3 FY27 as India multi-channel margin gains (NPM -0.5% this quarter) continue to build
W2
International segment loss trajectory — widened sequentially to ₹22.0 Cr this quarter from ₹18.9 Cr in Q1 FY27 despite management's breakeven call, with no specific quarter attached
W3
Pace toward management's guided 90-100 net new store additions in FY27 — not disclosed in this filing
Consolidated loss before exceptional items and tax for the quarter is ₹1.63 Cr — the main P&L table image reads ambiguously (OCR-prone) but the segment-information table and the PBT/tax/PAT tie-out confirm this, not a larger figure. Exceptional items (net) -₹2.19 Cr this quarter vs -₹3.43 Cr YoY relate to retirement-benefit remeasurement and inventory write-offs at step-down subsidiaries (Note v). Consolidated loss attributable to owners of the parent is ₹6.57 Cr (vs total group loss ₹12.59 Cr, balance to non-controlling interests). Standalone (parent-only) is profitable at ₹39.2 Cr while the consolidated group remains loss-making — driven by International and Globalbees D2C segment losses.
First Cry Q2: Path to Profitability in Focus as Acquisitions Reshape Portfolio
The e-commerce infant-products player reports amid ownership churn and an acquisition spree. Analysts are watching for margin recovery and guidance on the group's strategy post-restructuring.
What to Expect
First Cry reports Q2 FY-2027 on November 14, with the Street focused on two things: whether the company is maintaining revenue momentum on its post-IPO trajectory, and critically, evidence of margin expansion and operational efficiency as it integrates recent acquisitions. After reporting losses narrowing to ₹51 Cr in Q2 FY-2026, the consensus expectation is that Q2 FY-2027 will show continued progress toward breakeven, even as the portfolio expands. The real question: is acquisition-led growth accretive or dilutive to margins in the near term?
Consensus tracking on-plan
Street expects sustained QoQ and YoY trajectory; acquisition add-ons will flag consolidation timing
Path to breakeven watched
After narrowing to ₹51 Cr loss in Q2 FY26, investors are watching for inflection—especially post-acquisitions
Consolidation impact
42% stake acquired Nov 3, 14.23% in JW Brands Oct 30—will these be consolidated in Q2 or flagged separately?
Acquisition funding
Better & Brighter cost ₹16.26 Cr; total acquisition spend to signal capital allocation clarity
A strong quarter would show: revenue in line with guidance / run-rate; evidence of margin improvement (even if still unprofitable); clear disclosure of acquisition consolidation and integration progress; and management guidance affirming the group strategy post-restructuring. A weak quarter would include: revenue miss / deceleration; wider losses despite acquisitions; ambiguity on margins or integration timelines; or promotional activity hinting at demand weakness.
What the Street Says
Since Last Quarter
Brainbees has been active on the M&A front and regulatory front. On November 3, Globalbees (the subsidiary) acquired an additional 42% stake in Better & Brighter Homecare for ₹16.26 Cr in cash—flagging an expansion into adjacencies beyond core infant products. On October 30, an additional 14.23% stake in JW Brands was acquired, consolidating control of a third portfolio brand. Earlier in October, the NCLT New Delhi rejected an insolvency application against Globalbees filed by investors—a risk cleared. On October 7, Globalbees sold its 51.54% stake in Mush Textile for ₹5.69 Cr, shedding a non-core asset. The insider trading window closed October 1 ahead of result—standard compliance. On the ownership side, FII shareholding has declined from 7.03% (Q1 FY26) to 3.61% (Q1 FY27)—a 340 bp sell-off; DII has held steady around 22–24%, suggesting retail appetite remains soft.
1 · Revenue & Margin Trajectory
Validate whether losses are narrowing as expected; any acceleration in revenue despite macro headwinds; and management's commentary on when the company expects to approach breakeven.
2 · Acquisition Consolidation
Clarify which recent acquisitions are consolidated in Q2 FY27 vs. flagged separately; understand the acquisition rationale (customers, categories, brands, or financial engineering) and how these contribute to group economics.
3 · FY-2027 Guidance & Capital Allocation
Listen for full-year revenue / margin guidance, expected profitability milestone, and reinvestment vs. dividend policy. The cash position and capex outlook will signal whether acquisition spree continues or capital is redirected to organic growth.
Brainbees (First Cry) reports into a stock down 78% from its IPO peak, with analyst upside targets suggesting 43–49% recovery if the company can demonstrate margin inflection and disciplined M&A. Q2 FY-2027 is a checkpoint: does the company hold revenue momentum, and are recent acquisitions accretive to the path to profitability? The filings show aggressive portfolio expansion (three brand adds or deepenings in eight weeks); management must articulate how this fits the strategy and when it turns cash-flow positive. This is a story about execution—not forecast. Watch the actual numbers, margin trends, and guidance carefully.